Gaël R.
- Country
- France
- Department
- service hépato-gastroentérologie
Research Overview
- Evaluation of ASP3082 in Adult Patients with Advanced Solid Tumors
- Phase 1b Study of NP137 with Atezolizumab-Bevacizumab in First-Line Treatment of Unresectable Hepatocellular Carcinoma
- Phase III Study of Rilvegostomig plus Combination Chemotherapy versus Durvalumab plus Combination Chemotherapy in Patients with Advanced Biliary Tract Cancer
Data & Insights
Has run more than one trial at 141 of 292 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in advanced therapeutic approaches for gastrointestinal cancers, with particular emphasis on innovative treatment strategies for pancreatic adenocarcinoma and hepatocellular carcinoma.
- Pancreatic Cancer Treatment Innovation
- Liver Cancer Therapeutics
- Gastroesophageal Cancer Management
Focuses on developing combination therapies incorporating immunotherapy and targeted treatments for gastrointestinal malignancies.
Colorectal and Small Bowel Studies
Conducts research in the treatment of colorectal cancer and small bowel adenocarcinoma, with expertise in developing personalized therapeutic approaches.
- Circulating Tumor DNA Analysis
- Immunotherapy Combinations
- Advanced Chemotherapy Protocols
Investigates novel treatment strategies for both early-stage and metastatic disease states.
Precision Medicine Applications
Leads investigations in personalized medicine approaches for various digestive cancers, including biliary cancer and ampullary adenocarcinoma.
- Targeted Molecular Therapies
- Biomarker-Driven Treatment
- Maintenance Treatment Strategies
Explores innovative therapeutic combinations and maintenance strategies for advanced gastrointestinal malignancies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.